Back
Traws Pharma Stock Price Chart

Apple's Drop in iPhone Sales Opens the Door for New Entrant
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
17
TRAW
Traws Pharma
Last Price:
$2.43
Seasonality Move:
-9.22%
7 Day Trial
ALL ACCESS PASS
$
7

Meet the founder that's revolutionizing smartphones
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and TRAW is experiencing selling pressure, which indicates risk of future bearish movement.
Traws Pharma Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.69 | Sell |
20-day SMA: | 2.71 | Sell |
50-day SMA: | 4.88 | Sell |
200-day SMA: | 7.2 | Sell |
8-day EMA: | 2.63 | Sell |
20-day EMA: | 3.08 | Sell |
50-day EMA: | 4.33 | Sell |
200-day EMA: | 7.84 | Sell |
Traws Pharma Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.64 | Sell |
Relative Strength Index (14 RSI): | 28.95 | Sell |
Chaikin Money Flow: | -19768 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (2.38 - 3.52) | Sell |
Bollinger Bands (100): | (3.26 - 7.8) | Sell |
Traws Pharma Technical Analysis
Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
17 | 18 | 19 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Traws Pharma Stock
Is Traws Pharma Stock a Buy?
-
Traws Pharma share price is 2.40 while TRAW 8-day simple moving average is 2.69, which is a Sell signal.
-
The stock price of TRAW is 2.40 while Traws Pharma 20-day SMA is 2.71, which makes it a Sell.
-
Traws Pharma 50-day simple moving average is 4.88 while TRAW share price is 2.40, making it a Sell technically.
-
TRAW stock price is 2.40 and Traws Pharma 200-day simple moving average is 7.20, creating a Sell signal.
TRAW Technical Analysis vs Fundamental Analysis
Sell
17
Traws Pharma (TRAW)
is a Sell
Is Traws Pharma a Buy or a Sell?
-
Traws Pharma stock is rated a SellThe current Traws Pharma [TRAW] share price is $2.40. The Score for TRAW is 17, which is 66% below its historic median score of 50, and infers higher risk than normal.
Traws Pharma Stock Info
Market Cap:
7.3M
Price in USD:
2.40
Share Volume:
26.6K
Traws Pharma 52-Week Range
52-Week High:
27.50
52-Week Low:
2.02
Sell
17
Traws Pharma (TRAW)
is a Sell
Traws Pharma Share Price Forecast
-
What is the Traws Pharma stock price today?The Traws Pharma stock price is 2.40 USD today.
-
Will TRAW stock go up or go down?Traws Pharma> share price is forecast to RISE/FALL based on technical indicators
-
Is Traws Pharma overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Traws Pharma is overvalued.
Is Traws Pharma Stock a Buy?
-
Traws Pharma share price is 2.40 while TRAW 8-day exponential moving average is 2.63, which is a Sell signal.
-
The stock price of TRAW is 2.40 while Traws Pharma 20-day EMA is 3.08, which makes it a Sell.
-
Traws Pharma 50-day exponential moving average is 4.33 while TRAW share price is 2.40, making it a Sell technically.
-
TRAW stock price is 2.40 and Traws Pharma 200-day simple moving average is 7.84, creating a Sell signal.
Technical Analysis of Traws Pharma
Should I short Traws Pharma stock?
-
TRAW Moving Average Covergence Divergence (MACD) indicator is -0.64, suggesting Traws Pharma is a Sell
-
Traws Pharma Relative Strength Index (RSI) is 28.95, which suggest Traws Pharma is oversold
-
The Bollinger Bands (25) for Traws Pharma is (2.38 - 3.52), which suggest Traws Pharma is a Sell
-
The Bollinger Bands (100) for Traws Pharma is (3.26 - 7.8), which suggest Traws Pharma is a Sell
* Traws Pharma stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.